SCHEMBL22708418

SCHEMBL22708418

c1ccc(-c2cc3oc4c(ccc5[nH]c6ccccc6c54)c3c3ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ GABRP O00591 1/20 0.43
▸ GABRD O14764 1/20 0.43
▸ GABRA1 P14867 1/20 0.43
▸ GABRB1 P18505 1/20 0.43
▸ GABRG2 P18507 1/20 0.43
▸ GABRB3 P28472 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ GABRA3 P34903 1/20 0.43
▸ GABRA2 P47869 1/20 0.43
▸ GABRB2 P47870 1/20 0.43
▸ GABRA4 P48169 1/20 0.43
▸ GABRE P78334 1/20 0.43
▸ GABRA6 Q16445 1/20 0.43
▸ GABRG1 Q8N1C3 1/20 0.43
▸ GABRG3 Q99928 1/20 0.43
▸ GABRQ Q9UN88 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22708395 0.91 CDK4 (0.48) HPGDMAPK1HTTSMN1; SMN2GABRP
SCHEMBL22708623 0.85 CDK4 (0.34) HPGDMAPK1HTTSMN1; SMN2GABRP
SCHEMBL22708473 0.85 GABRP (0.38) HPGDSMN1; SMN2GABRPGABRDGABRA1
SCHEMBL22708472 0.84 HPGD (0.46) HPGDMAPK1HTTSMN1; SMN2GABRP
SCHEMBL22708416 0.83 HPGD (0.45) HPGDMAPK1HTTSMN1; SMN2GABRP
SCHEMBL22708467 0.82 GABRP (0.35) HPGDHTTSMN1; SMN2GABRPGABRD
SCHEMBL22708443 0.82 CDK4 (0.47) HPGDGABRPGABRDGABRA1GABRB1
SCHEMBL22708646 0.82 ALOX5 (0.45) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL22708610 0.81 GABRP (0.38) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL22708682 0.81 HPGD (0.45) HPGDMAPK1HTTSMN1; SMN2GABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same LT MATERIALS CO., LTD. (KR) 2023-02-21 — — US disclosed
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2020-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588110-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 HPGD 766/4885MAPK1 679/4885HTT 2061/4885
US-20200373499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 HPGD 766/4885MAPK1 679/4885HTT 2061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback